Seneste opdatering :
19/11/2024
Antibiotisk   Teicoplanine  
Injektion
Stabilitet i (vandige) opløsninger Stabilitet i blandinger Faktorer der påvirker stabiliteten Kompatibilitet Administrationsvej Bibliografi pdf
   Kemisk struktur  

Handelsnavn   Handelsnavn     

Handel navne er vejledende og hjælpestoffer sammensætning kan være forskellig afhængigt af landet og laboratorier

Bactomax Brasilien
Celplanin Indien, Marokko, Østrig
Heptacidin Mexico
Koplan Brasilien
Pitil Chile
Plavital Mexico
Sinbaken Mexico
Targocid Argentina, Australien, Belgien, Brasilien, Chile, Colombia, Danmark, Finland, Forenede Arabiske Emirater, Frankrig, Grækenland, Holland, Iran, Irland, Kroatien, Luxemborg, Malaysia, Marokko, Mexico, New Zealand, Norge, Polen, Portugal, Schweiz, Slovenien, Spanien, Storbritanien, Sverige, Thailand, Tunesien, Tyrkiet, Ungarn, Ægypten, Østrig
Targosid Italien, Portugal
Teicoplanin Iran, Tyskland
Teicoplanina Chile, Mexico, Spanien
Teicox Argentina
Tekosit Tyrkiet
Tepladex Mexico
Teriplax Mexico
Ticocin Venezuela
Zicoplanin Indien
Bibliografi   Injektion   Bibliografi : Teicoplanine  
Type offentliggørelse
289 Journal Jim LK.
Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
Ann Pharmacotherapy 1993 ; 27: 704-707.
1608 Journal Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J.
Assessment of the stability of teicoplanin in intravenous infusions.
Int J Pharm Compound 2001 ; 5: 397-400.
2057 Journal Droste JC, Jeraj HA, MacDonald A, Farrington K.
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.
J Antimicrob Chemother 2003 ; 51: 849-855.
2450 Journal Manduru M, Fariello A, White RL, Fox JL, Bosso JA.
Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution
Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734.
3656 Laboratorium Teicoplanine (Targocid®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2014
3728 Journal Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3976 Journal Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4440 Journal Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.
Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.
Ann Nutr Metab 2018 ; 73: 227-233.
4444 Journal Tounian P, Jehl F, Pauliat S, Morgant G, Ghirardi L, Selva M.A, Fontaine J.L, Aymard P, Girardet J.P.
Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics.
Clinical Nutrition 1999 ; 19, 3: 159-165.

  Mentions Légales